Hawthorn

Heinerman J, 1996, Heinerman's Encyclopedia of Healing Herbs and Spices.

Hobbs C, 1990, Hawthorn: a literature review, Herbal Gram, 22, 19

Leung AY, 1996, Encyclopedia of Common Natural Ingredients: Used in Food, Drugs, and Cosmetics.

10.1142/0284

Zhongguo yi xue ke xue yuan yao wu yan jiu suo et al, 1984, Zhong Yao Zhi.

Tyler VE, 1993, The Honest Herbal: A Sensible Guide to the Use of Herbs and Related Remedies.

McCaleb RS, 2000, The Encyclopedia of Popular Herbs: Your Complete Guide to the Leading Medicinal Plants.

The Pharmacopoeia Commission of PRC, 1997, Pharmacopoeia of the People's Republic of China.

10.1055/s-2006-959493

Blumenthal M, 2000, Herbal Medicine: Expanded Commission E Monographs.

10.1016/0021-9673(94)80541-5

Mills S, 2000, Principles and Practice of Phytotherapy: Modern Herbal Medicine.

10.1016/0031-9422(83)83048-9

Gao GY, 1995, Analysis of the chemical constituents of hawthorn fruits and their quality evaluation, Yaoxue Xuebao, 30, 138

10.1055/s-2007-971254

Occhiuto F, 1986, Comparative study of the cardiovascular activity of the young shoots, leaves and flowers of Crataegus oxyacantha: II. Action of extracts and isolated pure active principles on the isolated rabbit heart, Plantes Medicinales Et Phytotherapie, 20, 52

Bohinc P, 1987, Hawthorn, Crataegus, and its therapeutics, Medicinski Razgledi, 26, 53

Li L, 1984, Studies on hawthorn (Crataegus pinnatifida) and its active principle: I. Effect on myocardial ischemia and hemodynamics in dogs, Journal of Traditional Chinese Medicine, 4, 289

Popping S, 1995, Effect of a hawthorn extract on contraction and energy turnover of isolated rat cardiomyocytes, Arzneimittel Forschung, 45, 1157

Schussler M, 1995, Myocardial effects of flavonoids from Crataegus species, Arzneimittel Forschung, 45, 842

10.1055/s-2007-971497

Antsyshkina AM, 1990, On the pharmacological activity of hawthorn preparations, Farmatsiya, 39, 63

Costa R, 1986, Comparative study of the cardiovascular activity of the young shoots, leaves and flowers of Crataegus oxyacantha: III. Protective action on the isolated rat heart against arrhythmogenic agents and reperfusion arrhythmias, Plantes Medicinales Et Phytotherapie, 20, 115

Occhiuto F, 1986, Comparative study of the cardiovascular activity of the young shoots, leaves and flowers of Crataegus oxyacantha: I. Electrical activity and arterial pressure in the rat, Plantes Medicinales Et Phytotherapie, 20, 115

10.3109/13880208709055196

10.1002/1099-1573(200009)14:6<428::AID-PTR618>3.0.CO;2-L

Rewerski W, 1967, Pharmacological properties of flavan polymers isolated from hawthorn (Crataegus oxyacantha), Arzneimittel Forschung, 17, 490

Haslam E, 1989, Plant Polyphenols: Vegetable Tannins Revisited.

Twaij HAA, 1987, Crataegus azarolus Linn; pharmacology and phytochemistry: Part I. Pharmacology, Journal of Biological Sciences Research, 18, 105

10.1016/S0024-3205(98)00476-7

10.1016/S0024-3205(00)00608-1

10.3164/jcbn.20.211

Shanthi S, 1994, Hypolipidemic activity of tincture of Crataegus in rats, Indian J Biochem Bio, 31, 143

10.1159/000424470

Li HR, 1988, Antiatherosclerotic properties of medicinal plants, Khimiko-Farmatsevticheskii Zhurnal, 22, 1236

10.1016/0021-9150(96)05813-3

Bahorun T, 1996, Oxygen species scavenging activity of phenolic extracts from hawthorn fresh plant organs and pharmaceutical preparations, Arzneimittel Forschung, 46, 1086

10.1016/S0955-2863(00)00137-6

Lin QS, 2000, Molecular mechanism of hawthorn and its flavonoids in prevention on lipid metabolism disorder in rats, YingyangXuebao, 22, 131

10.1055/s-2006-962723

Weikl VA, 1996, Crataegus Special Extract WS 1442: assessment of objective effectiveness in patients with heart failure (NYHA II), Fortschritte der Medizin, 114, 291

Bodigheimer K, 1994, Effectiveness of hawthorn extract at a dosage of 3 × 100 mg per day: multicentre double‐blind trial with 85 NYHA stage II heart failure patients, Munchener Medizinische Wochenschrift, 136, S7

10.1016/S0944-7113(11)80018-8

Tauchert M, 1994, Effectiveness of hawthorn extract LI 132 compared with the ACE inhibitor coptopril: multicentre double‐blind study with 132 NYHA stage II heart failure patients, Munchener Medizinische Wochenschrift, 136, 27

Leuchtgens VH, 1993, Crataegus Special Extract WS 1442 in HYHA II heart failure: a placebo controlled randomized double‐blind study, Fortschritte der Medizin, 111, 352

Von‐Eiff M, 1994, Hawthorn/passionflower extract and improvement in physical exercise capacity of patients with dyspnoea class II of the NYHA functional classification, Acta Ther, 20, 47

Weng WL, 1984, Therapeutic effect of Crataeguspinnatifida on 46 cases of angina pectoris: a double blind study, Journal of Traditional Chinese Medicine, 4, 293

Hanak Th, 1983, Treatment of mild stable forms of angina pectoris with a standardized Crataegus extract, Therapiewoche, 33, 4331

10.1055/s-2007-971539

10.1016/0197-2456(95)00134-4

10.1089/act.1995.1.191

Hiyama T, 1969, Acute toxicity of Crataegutt extracts, Toho Igakkai Zasshi, 16, 68

Manolov P, 1969, Pharmacological study of a preparation based on a flavonoid mixture from Crataegus monogyna, Farmatsiya, 19, 38

Wojciech LV, 1967, Pharmacological properties of flavan polymers isolated from hawthorn (Crataegus oxyacantha), Arzneimittel Forschung, 17, 490

McGuffin M, 1997, Botanical Safety Handbook.

Murray M, 1996, A Textbook of Natural Medicine.